According to Teva, injuries have been described as “severe redness, cracked skin, blistering or welts, and burns or scars where the patch was worn.” Read more
While the negotiated deal benefited Teva and GSK, the deal was not structured with any concern or interest for purchasers or consumers who need treatment for epilepsy, bipolar disorder, and... Read more
A Pennsylvania federal judge said last month that he would approve a $512 million settlement between direct purchasers and Teva Pharmaceutical Industries Ltd. and its subsidiaries Cephalon I... Read more
A Massachusetts federal judge has given tentative approval to a $24 million settlement between Teva Pharmaceutical Industries Ltd. and class action Plaintiffs in a pay-for-delay case over ge... Read more
Teva Pharmaceutical Industries Ltd. and subsidiaries Cephalon Inc. and Barr Pharmaceuticals Inc. have agreed to pay $512 million to settle with the direct purchasers in pay-for-delay litigat... Read more
The United States Supreme Court has declined to review a California appellate court’s decision allowing a state law failure-to-warn claim to proceed against several generic drug manufacturer... Read more
Drug maker Teva has agreed to pay $285 million to settle cases alleging that oversized vials of the anesthetic propofol caused an outbreak of hepatitis C in 2008. The settlement resolves ove... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.